Utility of noninvasive genome-wide screening: a prospective cohort of obstetric patients undergoing diagnostic testing
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (7) , 1341-1348
Abstract
No abstract availableKeywords
Funding Information
- Brigham and Women’s Hospital
This publication has 20 references indexed in Scilit:
- Screening for Fetal Chromosomal AbnormalitiesObstetrics & Gynecology, 2020
- Social and medical need for whole genome high resolution NIPTMolecular Genetics & Genomic Medicine, 2019
- Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2018
- Clinical experience of laboratory follow‐up with noninvasive prenatal testing using cell‐free DNA and positive microdeletion results in 349 casesPrenatal Diagnosis, 2018
- ACOG and SMFM guidelines for prenatal diagnosis: Is karyotyping really sufficient?Prenatal Diagnosis, 2018
- Practice Bulletin No. 162Obstetrics & Gynecology, 2016
- Changing indications for invasive testing in an era of improved screeningSeminars in Perinatology, 2016
- Clinical outcome of subchromosomal events detected by whole‐genome noninvasive prenatal testingPrenatal Diagnosis, 2015
- Copy-Number Variation and False Positive Prenatal Aneuploidy Screening ResultsNew England Journal of Medicine, 2015
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012